Pharmafile Logo
Pharmafocus logo
Advanced Search

Understanding Which Types of Design Should Be Driving Innovation at Drug Delivery Device Suppliers

November 20, 2013
Manufacturing and Production auto injector, autoinjector, autoinjector innovation, shl autoinjector

SHL’s recent article “Understanding Which Types of Design Should Be Driving Innovation at Drug Delivery Device Suppliers” was featured in …

Feature
Thought Leadership

SHL introduces new mobile website

November 20, 2013
Manufacturing and Production shl group, shl mobile, shl social media

SHL recently introduced a mobile website which allows mobile device users to view the company’s corporate website in a more …

News
Press release

Pfizer launches another ‘medicine optimisation’ campaign

November 19, 2013
Medical Communications Pfizer, RPS, npa, treatments

Patients would be more likely to follow prescriptions if they had better knowledge about the drugs they were taking according …

News
Prescribing image

Charge more for prescriptions in England, say Reform

November 19, 2013
Sales and Marketing GP, NHS, UK, doctors, prescriptions, reform

Increase prescriptions to £10 and charge the same amount to see a GP if you want to help the NHS …

News
Merck image

Merck’s melanoma vaccine impresses

November 19, 2013
Research and Development, Sales and Marketing MK-3475, Merck, Roche, melanoma

Merck has posted impressive results for its new melanoma vaccine MK-3475 as it looks to vie for a place in …

News
screen_shot_2013-11-19_at_08

Immunocore promotes non-executive to chairman

November 19, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing immunocore, knowles

Oxford-based biotech firm Immunocore has appointed Dr Jonathan Knowles as the new executive chairman of its Board of directors. Knowles …

Appointment
Sanofi image

Sanofi discards blood cancer drug in late-stage

November 19, 2013
Research and Development, Sales and Marketing Sanofi, Wernicke's encephalopathy, fedratinib

Sanofi has scrapped its regulatory filing plans and late-stage trials for rare bone marrow cancer treatment fedratinib. The reason given …

News
cancer image

Scientists map cancer ‘family tree’

November 18, 2013
Research and Development, Sales and Marketing Cancer, DNA, ICR, family tree

A method to take the DNA fingerprint of individual cancer cells is uncovering the true extent of cancer’s genetic diversity …

News
Xofigo

Bayer cancer drug gets EU approval

November 18, 2013
Sales and Marketing Bayer, CHMP, EU, Xtandi, Zytiga, xofigo

Bayer’s prostate cancer treatment Xofigo has been shown the green light by the European Commission.  Xofigo (radium Ra 223 dichloride) …

News
China image

Merck and J&J invest in Chinese manufacturing

November 18, 2013
Manufacturing and Production J&J, JJ, Merck, manufacturing

Merck KGaA and Johnson & Johnson have both announced new manufacturing projects in China, suggesting investigations into corruption by the …

News
Lilly image

Lilly plans $700m insulin plant expansion programme

November 18, 2013
Manufacturing and Production Taylor, lilly, manufacturing

Eli Lilly has said it will invest more than $700 million to expand its production capacity for insulin products in …

News
EMA image

UK agency urged to ‘press’ EMA on speed reviews

November 18, 2013
Research and Development, Sales and Marketing BIA, EMA, EU, MHRA

A new advisory group for the UK drugs regulator wants Europe to follow the lead of the US by introducing …

News
NICE image

NICE tells pharma: don’t blame us for rejections

November 18, 2013
Sales and Marketing Dillon, NHS, NICE, VBP

The head of NICE has publicly defended his agency against more pharma criticism but admits that it can make changes …

News

Pharma facility news in brief

November 18, 2013
Manufacturing and Production Actavis, Bend Research and WuXi PharmaTech, China Pharma, GlaxoSmithKline, manufacturing, nibs

GlaxoSmithKline is planning to boost in-house production of pharmaceuticals in India by building a brand new facility with an investment …

News
giovanni-caforio-2011-2

Several leadership changes at Bristol-Myers Squibb

November 18, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS

BMS has made several modifications to its senior management team with appointments and role shuffles being the order of the …

Appointment
Hunt image

Is the NHS in safe hands?

November 18, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hunt, Lansley, McConaghie, NHS

A total of 16 months have passed since Jeremy Hunt took over as health secretary from Andrew Lansley, and in …

Feature

Most health apps have ‘limited value’

November 15, 2013
Medical Communications, Sales and Marketing Android, digital, healthcare apps, smartphone apple

In a challenge to pharma marketers everywhere, a new report has declared that the ‘vast majority’ of health-related apps aimed …

News

‘Old fashioned’ doctors in new GP contract

November 15, 2013
Sales and Marketing BMA, GP, Hunt, Labour, NHS, UK, doctors

The government is changing GPs’ contract with the NHS in a bid to “bring back old-fashioned family doctors” who will …

News

Pharma slams PPRS deal

November 15, 2013
Medical Communications, Sales and Marketing ABPI, PPRS, VBP, telegraph

The fallout from last week’s new drug pricing plan in the UK is continuing as nine pharma firms write an …

News
g_kelly_martin_questcor

Questcor adds Elan president to its Board

November 15, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Elan, Questcor, martin

Biopharma firm Questcor Pharmaceuticals has appointed Elan’s president and chief executive G. Kelly Martin to its Board of directors. Martin has …

Appointment
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026